New insider Craig Ryan R claimed ownership of 4,383 shares (SEC Form 3)
$ELV
Medical Specialities
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/11/2025 |
3. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 4,383(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (Right to Buy) | (2) | 03/01/2034 | Common Stock | 965 | $499.11 | D | |
| Employee Stock Option (Right to Buy) | (3) | 03/03/2035 | Common Stock | 1,201 | $395.5 | D | |
| Explanation of Responses: |
| 1. Includes 3,341 restricted share units which vest on varying dates between 2/1/2026 and 3/3/2028. |
| 2. The option represents a right to purchase a total of 965 shares, and is exercisable in three annual installments, with one installment of 321 shares and two installments of 322 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. |
| 3. The option represents a right to purchase a total of 1,201 shares, and is exercisable in three annual installments, with two installments of 400 shares each and one installment of 401 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date. |
| Remarks: |
| Exhibit List: Exhibit 24 - Power of Attorney The reporting person's Form ID application was pending as of the Form 3 filing deadline, preventing an electronic filing. A paper Form 3 was delivered to the SEC on August 21, 2025, and this electronic Form 3 was filed promptly upon issuance of EDGAR codes. |
| /s/ Kathleen S. Kiefer, Attorney in fact | 08/21/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||